Correlation Between Valneva SE and Checkpoint Therapeutics

Can any of the company-specific risk be diversified away by investing in both Valneva SE and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Valneva SE ADR and Checkpoint Therapeutics, you can compare the effects of market volatilities on Valneva SE and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Checkpoint Therapeutics.

Diversification Opportunities for Valneva SE and Checkpoint Therapeutics

-0.51

Correlation Coefficient

Valneva SE  Checkpoint Therapeutics

Excellent diversification

The 3 months correlation between Valneva and Checkpoint is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Checkpoint Therapeutics go up and down completely randomly.

Pair Corralation between Valneva SE and Checkpoint Therapeutics

Given the investment horizon of 90 days Valneva SE ADR is expected to generate 1.15 times more return on investment than Checkpoint Therapeutics. However, Valneva SE is 1.15 times more volatile than Checkpoint Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Checkpoint Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  387.00  in Valneva SE ADR on December 2, 2024 and sell it today you would earn a total of  288.00  from holding Valneva SE ADR or generate 74.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Valneva SE ADR  vs.  Checkpoint Therapeutics

Valneva SE ADR

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Valneva SE ADR are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Valneva SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Checkpoint Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Checkpoint Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Valneva SE and Checkpoint Therapeutics

The main advantage of trading using opposite Valneva SE and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.

The idea behind Valneva SE ADR and Checkpoint Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.